What are Juliet Thompson’s Indivior (INDV) share holdings after these transactions?

Following the reported transactions, she directly holds 12,973 shares of Indivior common stock. She also has an indirect holding of 5,775 shares classified as "By Spouse," reflecting shares owned through her spouse rather than in her own name.

Indivior (INDV) director granted 6,518 RSUs, 1,117 shares withheld for taxes

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Indivior Pharmaceuticals director Juliet Thompson reported routine equity compensation and related tax withholding transactions. She received a grant of 6,518 Restricted Stock Units, each representing one share of common stock, which will vest immediately before the next annual stockholder meeting if she continues serving the company.

To satisfy tax withholding obligations from RSU vesting on May 12, 2026, 1,117 shares of common stock were withheld at a price of $38.28 per share, which is not an open-market sale. After these transactions, Thompson holds 12,973 shares directly and 5,775 shares indirectly through her spouse.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Thompson Juliet

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	6,518	$0.00	--
Tax Withholding	Common Stock	1,117	$38.28	$43K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 12,973 shares (Direct, null); Common Stock — 5,775 shares (Indirect, By Spouse)

Footnotes (1)

Shares used to satisfy tax withholding obligations associated with the vesting of Restricted Stock Units on May 12, 2026. Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the day immediately preceding the date of the annual meeting of the Issuer's stockholders following the date of grant, subject to the Reporting Person's continued service to the Issuer on the vesting date.

Key Figures

RSU grant: 6,518 RSUs Tax withholding shares: 1,117 shares Tax withholding price: $38.28 per share +3 more

6 metrics

RSU grant 6,518 RSUs Grant of Restricted Stock Units to director on May 13, 2026

Tax withholding shares 1,117 shares Shares used to satisfy tax withholding on May 12, 2026

Tax withholding price $38.28 per share Price for F-code tax-withholding disposition

Direct holdings after grant 12,973 shares Direct common stock ownership following RSU grant

Direct holdings after withholding 6,455 shares Direct shares following F-code tax withholding transaction

Indirect spouse holdings 5,775 shares Common stock held indirectly "By Spouse"

Key Terms

Restricted Stock Units (RSUs), tax withholding obligations, annual meeting of the Issuer's stockholders, indirect ownership

4 terms

Restricted Stock Units (RSUs) financial

"Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share"

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

tax withholding obligations financial

"Shares used to satisfy tax withholding obligations associated with the vesting of Restricted Stock Units"

annual meeting of the Issuer's stockholders financial

"The RSUs vest on the day immediately preceding the date of the annual meeting of the Issuer's stockholders"

indirect ownership financial

"transaction_type" : "holding" ... "direct_or_indirect" : "I", "nature_of_ownership" : "By Spouse""

Form 4 Insider Transactions: What Each Field Means →

05/14/2026 - 04:12 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Thompson Juliet

(Last)

(First)

(Middle)

10710 MIDLOTHIAN TURNPIKE

SUITE 125

(Street)

NORTH CHESTERFIELD

VIRGINIA

23235

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Indivior Pharmaceuticals, Inc. [ INDV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/12/2026		F		1,117⁽¹⁾	D	$38.28	6,455	D
Common Stock	05/13/2026		A		6,518⁽²⁾	A	$0	12,973	D
Common Stock								5,775	I	By Spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Shares used to satisfy tax withholding obligations associated with the vesting of Restricted Stock Units on May 12, 2026.

2. Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the day immediately preceding the date of the annual meeting of the Issuer's stockholders following the date of grant, subject to the Reporting Person's continued service to the Issuer on the vesting date.

Remarks:

	/s/Alice Givens, Power of Attorney	05/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did Indivior (INDV) director Juliet Thompson report?

Juliet Thompson reported an equity grant and related tax withholding. She received 6,518 Restricted Stock Units and had 1,117 shares withheld at $38.28 to cover taxes from RSU vesting, along with updated direct and indirect share holdings.

How many Indivior (INDV) shares did Juliet Thompson acquire in this Form 4?

She acquired 6,518 Restricted Stock Units, each equal to one share of common stock. These RSUs vest the day before the next annual stockholder meeting, contingent on her continued service as a director through that vesting date.

Were any of Juliet Thompson’s Indivior (INDV) transactions open-market sales?

No, the Form 4 shows 1,117 shares disposed solely to satisfy tax withholding obligations at $38.28 per share. This F‑code transaction is a tax-withholding mechanism, not an open-market sale reflecting a discretionary sell decision.

When do Juliet Thompson’s new Indivior (INDV) RSUs vest?

The 6,518 Restricted Stock Units vest on the day immediately before the next annual stockholder meeting. Vesting is conditioned on her continued service to Indivior as of that vesting date, as described in the Form 4 footnote.